Chau-Yin Chen

Dr. Chau-Yin Chen


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
JWJin-Jhe Wang
Jin-Jhe Wang
Chien-Hsiung LaiChien-Hsiung Lai
Chien-Hsiung Lai
CCChau-Yin Chen
Chau-Yin Chen
CLChia-Yen Liu
Chia-Yen Liu
MLMeng-Hung Lin
Meng-Hung Lin
PWPei-Lun Wu
Pei-Lun Wu
Infectious keratitis (IK) represents a major cause of corneal blindness. This study aims to investigate the demographics, risk factors, microbiological characteristics and antibiotic susceptibility patterns of IK in Taiwan over the past 15 years. A retrospective population-based study was conducted using the Chang Gung Research Database. Patients with IK were identified by diagnostic codes for corneal ulcer from 2004 to 2019. Of 7807 included subjects, 45.2% of patients had positive corneal cultures. The proportion of contact lens-related IK declined, while that of IK related to systemic diseases grew. The percentage of isolated gram-positive bacteria surpassed that of gram-negative bacteria in the 15-year period. The prevalence of Pseudomonas aeruginosa showed a decreasing trend (p = 0.004), whereas coagulase-negative Staphylococcus (CNS) and Propionibacterium species were increasingly detected (p < 0.001). Overall, the trend of antibiotic susceptibility of both gram-positive and gram-negative bacteria did not change throughout the study period. The susceptibility to the test antibiotics maintained over 90% in gram-negative isolates over 15 years. Vancomycin preserved 100% susceptibility to all gram-positive isolates. Since most tested antibiotics exhibited stable susceptibility over decades, this study reinforced that fluoroquinolones and fortified vancomycin continue to be good empiric therapies for treating bacterial keratitis in Taiwan.

JWJin-Jhe Wang
Jin-Jhe Wang
Chien-Hsiung LaiChien-Hsiung Lai
Chien-Hsiung Lai
TKTing-Yu Kuo
Ting-Yu Kuo
MLMeng-Hung Lin
Meng-Hung Lin
YYYao-Hsu Yang
Yao-Hsu Yang
CCChau-Yin Chen
Chau-Yin Chen
Obesity has been regarded as a risk factor for several ocular diseases. This study aims to investigate the age- and sex-specific relationship between epiblepharon and obesity in children. A retrospective case–control study was conducted using the Chang Gung Research Database. Children ≤ 18 years of age with epiblepharon were identified from 1 January 2009 to 31 December 2019. Children were classified into three groups: normal, overweight and obese groups. A total of 513 patients and 1026 controls (57.7% males) aged 1 to 18 matched by sex and age were included in the analysis. The median body mass index (BMI) of children with epiblepharon was significantly higher than that of children without epiblepharon (p < 0.001). In the subgroup analysis, among boys aged 4 to 9 years, the BMI in boys with epiblepharon was significantly higher than that in boys without epiblepharon (p < 0.05) and the risk of epiblepahron in overweight/obese boys was significantly higher than in non-overweight boys (OR = 1.74, 95% CI = 1.07–2.82 for age 4 to 6; OR = 3.06, 95% CI = 1.56–6.03 for age 7 to 9). On the other hand, among girls aged 13 to 18 years, the BMI in adolescent girls with epiblepharon was significantly higher than that in the control group (p < 0.05) and overweight/obese girls had a statistically higher risk of persistent epiblepharon than non-overweight girls (OR = 3.70, 95% CI = 1.38–9.97). The association between obesity and epiblepharon varies in strength according to age in a sex-specific manner.

Verified
Journal Article
Open access
PDF file
NCNan Ni Chen
Nan Ni Chen
CCChau-Yin Chen
Chau-Yin Chen
JWJin-Jhe Wang
Jin-Jhe Wang
HHHeng-Chiao Huang
Heng-Chiao Huang
WCWei-Dar Chen
Wei-Dar Chen
Chien-Hsiung LaiChien-Hsiung Lai
Chien-Hsiung Lai
(1) To investigate the functional and anatomical outcomes of anti-vascular endothelial growth factor (anti-VEGF) treatment in patients with exudative age-related macular degeneration (AMD) with or without obstructive sleep apnea (OSA); (2) In total, 65 patients with AMD with or without OSA who received three consecutive doses of intravitreal anti-VEGF injections were enrolled. The primary outcomes—best-corrected visual acuity (BCVA) and central macular thickness (CMT)—were assessed at 1 and 3 months. Moreover, morphological changes observed through optical coherence tomography were analyzed; (3) In total, 15 of the 65 patients had OSA and were included in the OSA group; the remaining 50 patients were included in the non-OSA (control) group. At 1 and 3 months after treatment, BCVA and CMT had improved but did not differ significantly between the groups. More patients in the OSA group demonstrated subretinal fluid (SRF) resorption at 3 months after treatment than in the non-OSA group (p = 0.009). Changes in other imaging biomarkers, such as intraretinal cysts, retinal pigment epithelium detachment, hyperreflective dots, and ellipsoid zone disruptions, did not differ significantly between the groups; (4) Our results suggest that the BCVA and CMT outcomes 3 months after anti-VEGF treatment are similar between patients with and without OSA. Moreover, patients with OSA may exhibit superior SRF resorption. A large-scale prospective study is mandatory to evaluate the association between SRF resorption and visual outcomes in AMD patients with OSA.

Verified
Journal Article
Open access
PDF file
NCNan Ni Chen
Nan Ni Chen
Chien-Hsiung LaiChien-Hsiung Lai
Chien-Hsiung Lai
CLChia-Yi Lee
Chia-Yi Lee
CKChien-Neng Kuo
Chien-Neng Kuo
ACAnd Ching-Lung Chen
And Ching-Lung Chen
CCChau-Yin Chen
Chau-Yin Chen
(1) Background: To investigate the correlation between therapeutic outcome and morphologic changes for diabetic macular edema (DME) after intravitreal injection of ranibizumab (IVIR). (2) Methods: This retrospective study included 228 eyes received IVIR for DME. Each participant was traced for two years after the initial IVIR, while the data of ophthalmic examination, optical coherence tomography (OCT) image, and systemic diseases were collected. The study population was categorized into different subgroups according to the existence of OCT morphologic change and the initial OCT morphologic pattern, including diffuse retinal thickening (DRT), cystoid macular edema (CME), serous retinal detachment (SRD), and vitreomacular interface abnormalities (VMIAs). The primary outcomes were the baseline best-corrected visual acuity (BCVA) and central macular thickness (CMT) during a two-year study period. The distribution of OCT morphologic change and its relation to primary outcome were analyzed. (3) Results: Comparing the 42 eyes (18.4%) with OCT morphological changes to another 186 eyes (81.6%) without such alteration, the former showed a poorer baseline BCVA (0.84 ± 0.39 vs. 0.71 ± 0.36, p = 0.035), worse final BCVA (0.99 ± 0.44 vs. 0.67 ± 0.30, p = 0.001), and thicker final CMT (354.21 ± 89.02 vs. 305.33 ± 83.05, p = 0.001). Moreover, the VMIA developed in 14.9% of all DME patients presenting the most common morphologic change among DRT, CME, and SRD. Besides, the presence of stroke was independently correlated to the morphologic change (adjusted odds ratio [aOR]: 6.381, 95% confidence interval (CI): 1.112–36.623, p = 0.038). (4) Conclusions: The change of OCT morphology in DME patients receiving IVIR was correlated to worse structural and visual outcome while the formation of VMIA most commonly occurred after initial treatment.

1 February 2024 in Retina
Verified
Journal Article
Closed access
YCYung-Kang Chen
Yung-Kang Chen
CLChien-Hsiung Lai
Chien-Hsiung Lai
NCNan-Ni Chen
Nan-Ni Chen
WWWei-Chi Wu
Wei-Chi Wu
XLXiao-Chun Ling
Xiao-Chun Ling
CCChau-Yin Chen
Chau-Yin Chen
An abstract is unavailable. This article is available as a PDF only.

4 January 2023
Verified
Book Chapter
Open access
PDF file
JWJin-Jhe Wang
Jin-Jhe Wang
YTYueh-Ju Tsai
Yueh-Ju Tsai
CCChau-Yin Chen
Chau-Yin Chen
Squamous cell carcinoma that arises from the eye and its adnexa has gained more attention as the incidence rises globally. The malignancy has a broad spectrum of clinical manifestations and, if not properly treated, may affect both vision and life. In this chapter, we will go over the squamous cell carcinoma that occurs on the ocular surface and its adnexa, including the eyelid and lacrimal apparatus. We would like to introduce the epidemiology, pathophysiology, diagnosis methods, recurrence and prognosis of this squamous neoplasm. Furthermore, we review most of the current treatment strategies for squamous cell carcinoma of the eyelid and ocular surface ranging from medical to surgical measures.